Market Research Future Has A Cooked Research Report On The Global Osteosarcoma Market. This Is Expected To Reach USD 62.19 Million By 2023
Osteosarcoma is a bone tumor that may occur in any bone of the body. Approximately 75% of cases, patients with osteosarcoma are between 15-25 years old. Male are more as often suffer from osteosarcoma than females.
Currently, chemotherapy for osteosarcoma is usually directed within prospective clinical trials. In drug treatment, doxorubicin is the first and most commonly used the drug for osteosarcoma patients. Cisplatin is the second most commonly used drug and is included in most of the protocols. High-dose methotrexate with leucovorin is the third most commonly used drug. These treatment methods are likely to boost the pharmaceutical industries resulting in the growth of the osteosarcoma market.
The global osteosarcoma market is expected to grow at a CAGR of 6.40% during the forecast period 2017-2023.
Taste the market data and market information presented through more than 128 market data tables and figures spread over 134 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Osteosarcoma market research report–Global forecast till 2023.”
Osteosarcoma Market Key Players:
Pfizer (U.S.), Novartis (U.S.), Spectrum Pharmaceuticals, Inc. (U.S.), Hikma Pharmaceuticals (U.K), Baxter (U.S.), Advaxis Inc., Bellicum Pharmaceuticals (U.S.), and Inc. Isofol Medical AB (Sweden).
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4412
Segmentation:
The Global Osteosarcoma Market is segmented on the basis of types, diagnosis, treatment, and end user.
On the basis of the types, it is further segmented into intramedullary osteosarcoma, juxtacortical osteosarcoma, and extra-skeletal osteosarcoma.
On the basis of the diagnosis, the market is segmented into biopsy, X-ray, MRI, CT Scan, bone scan, and others.
On the basis of the treatment, the market is segmented into chemotherapy, surgery, radiation therapy, and others.
On the basis of the end user, the market is segmented into hospitals & clinics, cancer research centers, and others.
Osteosarcoma Market Key Findings:
On the basis of type, intramedullary osteosarcoma is the fastest growing market and is expected to reach USD 62.19 million by 2023 from USD 36.34 million in 2016 at a CAGR of 6.81% during the forecast period of 2017-2023.
On the basis of diagnosis, biopsy is the fastest growing market, which is expected to reach USD 45.86 million by 2023 from USD 26.90 million in 2016, at a CAGR of 6.76% during the forecast period of 2017-2023.
On the basis of application, synthetic biology is the fastest growing market, which is expected to reach USD
Regional Analysis
The global osteosarcoma market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.
Constantly increasing the patient population of cancer, increasing the number of cases in children, and increasing government support for research in the healthcare domain drive the Americas market growth and remains responsible for making it one of the largest global market.
Europe holds the second position in the market due to increasing development and more focus on healthcare domain. Countries such as Germany and France are investing more in research & development to develop new treatment methods for various types of cancer. According to the European Cancer Organization, incidence rates of cancer diseases including osteosarcoma have increased by 41% and 50% respectively between 1993-1995 and 2012-2014. It is one of the major factors responsible for the growth of the market in this region.
The Asia Pacific is expected to be the fastest growing region in the global osteosarcoma market owing to emerging player and focus of established players in this region. Moreover, developing countries such as India, China, and the Republic of Korea are focusing on research & development and minimizing barriers to drug approval, which is projected to boost the market growth in this region.
On the other hand, the Middle East & Africa owns the minimum market share of the osteosarcoma market due to less development in the healthcare services such as new and advanced diagnosis & treatment methods in healthcare domain.
Brief TOC:
1 Report Prologue
2 Market Introduction
2.1 Definition 16
2.2 Scope Of The Study 16
2.2.1 Research Objective 16
2.2.2 Assumptions 16
2.2.3 Limitations 17
3 Research Methodology
3.1 Introduction 18
3.2 Primary Research 19
3.3 Secondary Research 19
3.4 Market Size Estimation 20
4 Market Dynamic
4.1 Introduction 22
4.2 Drivers 23
4.2.1 Rising Prevalence Of Osteosarcoma (25%) 23
4.2.2 Increasing Expenditure On Oncology Medicine And Research (45%) 24
4.2.3 Rising Demand For New Treatment (30%) 25
4.3 Restraints 26
4.3.1 High Cost Of Treatment 26
4.4 Technology Trends And Assessment 27
4.5 Macroeconomic Indicators 28
5 Market Factor Analysis
5.1 Value Chain Analysis 29
5.1.1 Research & Product Development 29
5.1.2 Formulation 30
5.1.3 Marketing & Sales 30
5.1.4 Finish Products 30
5.2 Porter’s Five Forces Model 31
5.2.1 Bargaining Power Of Suppliers 32
5.2.2 Bargaining Power Of Buyers 32
5.2.3 Threat Of New Entrants 32
5.2.4 Threat Of Substitutes 32
5.2.5 Intensity Of Rivalry 33
5.3 Pricing Analysis 33
5.4 Investment Opportunities 33
…Continued
Get Discounts @ https://www.marketresearchfuture.com/check-discount/4412
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Your information will never be shared with any third party.